A class of designs for Phase I cancer clinical trials combining Bayesian and likelihood approaches (Q3019496): Difference between revisions
From MaRDI portal
Created a new Item |
Added link to MaRDI item. |
||
| links / mardi / name | links / mardi / name | ||
Revision as of 21:35, 3 February 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A class of designs for Phase I cancer clinical trials combining Bayesian and likelihood approaches |
scientific article |
Statements
A class of designs for Phase I cancer clinical trials combining Bayesian and likelihood approaches (English)
0 references
28 July 2011
0 references
dose escalation
0 references
MTD
0 references
Bayesian
0 references
maximum likelihood
0 references
